10216 related articles for article (PubMed ID: 1317993)
1. Tissue breakdown and exposure associated with orbital hydroxyapatite implants.
Buettner H; Bartley GB
Am J Ophthalmol; 1992 Jun; 113(6):669-73. PubMed ID: 1317993
[TBL] [Abstract][Full Text] [Related]
2. Theoretical considerations in the placement of hydroxyapatite orbital implants.
Sires BS; Dortzbach RK; Holds JB
Ophthalmic Plast Reconstr Surg; 1997 Jun; 13(2):147-51. PubMed ID: 9185199
[No Abstract] [Full Text] [Related]
3. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants.
Nunery WR; Heinz GW; Bonnin JM; Martin RT; Cepela MA
Ophthalmic Plast Reconstr Surg; 1993 Jun; 9(2):96-104. PubMed ID: 8391837
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of the Allen implant. 1967 to 1991.
Fan JT; Robertson DM
Ophthalmology; 1995 Mar; 102(3):510-6. PubMed ID: 7891992
[TBL] [Abstract][Full Text] [Related]
5. Management of exposed hydroxyapatite orbital implants.
Kim YD; Goldberg RA; Shorr N; Steinsapir KD
Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570
[TBL] [Abstract][Full Text] [Related]
6. Enucleation with primary implant insertion for treatment of recalcitrant endophthalmitis and panophthalmitis.
Abel AD; Meyer DR
Ophthalmic Plast Reconstr Surg; 2005 May; 21(3):220-6. PubMed ID: 15942499
[TBL] [Abstract][Full Text] [Related]
7. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos.
Massry GG; Holds JB
Ophthalmology; 1995 Jan; 102(1):161-6. PubMed ID: 7831032
[TBL] [Abstract][Full Text] [Related]
8. [Enucleation with on-the-table evisceration. Is it a good technique?].
Duong MH; Barraco P; Schapiro D; Ben Ayed H; Morax S
J Fr Ophtalmol; 2001 Oct; 24(8):836-41. PubMed ID: 11894534
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic evidence of fibrovascular ingrowth four weeks after placement of the hydroxyapatite orbital implant.
Shields CL; Shields JA; Eagle RC; De Potter P
Am J Ophthalmol; 1991 Mar; 111(3):363-6. PubMed ID: 1848039
[TBL] [Abstract][Full Text] [Related]
10. Role of magnetic resonance imaging in the evaluation of the hydroxyapatite orbital implant.
De Potter P; Shields CL; Shields JA; Flanders AE; Rao VM
Ophthalmology; 1992 May; 99(5):824-30. PubMed ID: 1375714
[TBL] [Abstract][Full Text] [Related]
11. Use of the hydroxyapatite ocular implant in the pediatric population.
De Potter P; Shields CL; Shields JA; Singh AD
Arch Ophthalmol; 1994 Feb; 112(2):208-12. PubMed ID: 8311774
[TBL] [Abstract][Full Text] [Related]
12. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
Shields CL; Shields JA; De Potter P; Singh AD
Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
[TBL] [Abstract][Full Text] [Related]
13. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants.
el-Shahed FS; Sherif MM; Ali AT
Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):91-4. PubMed ID: 7654623
[TBL] [Abstract][Full Text] [Related]
14. Prevention and management of complications associated with the hydroxyapatite implant.
Kaltreider SA; Newman SA
Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):18-31. PubMed ID: 8652455
[TBL] [Abstract][Full Text] [Related]
15. Long term follow up of bone derived hydroxyapatite orbital implants.
Suter AJ; Molteno AC; Bevin TH; Fulton JD; Herbison P
Br J Ophthalmol; 2002 Nov; 86(11):1287-92. PubMed ID: 12386091
[TBL] [Abstract][Full Text] [Related]
16. Complications of porous spherical orbital implants.
Remulla HD; Rubin PA; Shore JW; Sutula FC; Townsend DJ; Woog JJ; Jahrling KV
Ophthalmology; 1995 Apr; 102(4):586-93. PubMed ID: 7536909
[TBL] [Abstract][Full Text] [Related]
17. Case series of shrinking hydroxyapatite orbital implants.
Han LS; Keillor RB; Weatherhead RG
Br J Ophthalmol; 2021 Oct; 105(10):1338-1340. PubMed ID: 34039563
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyapatite orbital implants. Experience with 100 cases.
McNab A
Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the exposure rate of wrapped hydroxyapatite (Bio-Eye) versus unwrapped porous polyethylene (Medpor) orbital implants in enucleated patients.
Tabatabaee Z; Mazloumi M; Rajabi MT; Khalilzadeh O; Kassaee A; Moghimi S; Eftekhar H; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2011; 27(2):114-8. PubMed ID: 20829725
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite motility implants in ocular prosthetics.
Cowper TR
J Prosthet Dent; 1995 Mar; 73(3):267-73. PubMed ID: 7760276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
